Procedural and Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous

Domenico Simone Castiello1, Federica Buongiorno1, Lina Manzi1

  • 1Department of Advanced Biomedical Sciences, University of Naples Federico II, 80138 Naples, Italy.

Insights

Patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) face high bleeding risks. This review explores strategies to balance antithrombotic therapy for optimal outcomes in this complex patient group.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Pharmacology

Background:

  • Percutaneous coronary intervention (PCI) is a primary treatment for coronary artery disease (CAD).
  • Dual antiplatelet therapy (DAPT) is crucial post-PCI, but many patients also require oral anticoagulants (OACs) for atrial fibrillation (AF).
  • Combining OACs with DAPT significantly elevates bleeding risk.

Purpose of the Study:

  • To review current procedural and antithrombotic strategies for patients with AF undergoing PCI.
  • To optimize the balance between preventing ischemic events and minimizing bleeding complications in this population.

Main Methods:

  • Review of existing literature on antithrombotic strategies in patients with AF undergoing PCI.
  • Comparison of dual antithrombotic therapy (DAT) versus triple antithrombotic therapy (TAT) regarding bleeding and thrombotic risks.
  • Discussion of procedural considerations to mitigate risks.

Main Results:

  • Dual antithrombotic therapy (DAT) reduces bleeding compared to triple antithrombotic therapy (TAT).
  • However, DAT may be associated with an increased risk of stent thrombosis.
  • Patients with AF undergoing PCI present unique challenges requiring tailored management.

Conclusions:

  • Managing antithrombotic therapy in AF patients undergoing PCI requires careful consideration of individual risk factors.
  • Strategies to reduce bleeding complications are essential.
  • Further research and optimized protocols are needed to improve both ischemic and bleeding outcomes.

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...